This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked FOLR1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-FOLR1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~29.8 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Glycosylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The M02254 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HEK293 cell lysate (catalog M02254) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02254; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
FOLR1 has a predicted 29.8 kDa precursor; cleavage and N-linked glycosylation could alter migration, but no empirical band size or demonstrated shift is supplied.
| Band near 29.8 kDa | Consistent with the predicted full-length precursor; identity needs confirmation |
| Band below 29.8 kDa | Could reflect signal-peptide or propeptide cleavage |
| Band above 29.8 kDa | Could reflect N-linked glycosylation at Asn69, Asn161, or Asn201 |
| Weak or absent lysate band | May reflect enrichment of GPI-anchored FOLR1 at the cell surface |
| Predicted precursor mass | Provides a 29.8 kDa sequence-based reference |
| N-linked glycosylation at Asn69 | May increase apparent mass |
| N-linked glycosylation at Asn161 | May increase apparent mass |
| N-linked glycosylation at Asn201 | May increase apparent mass |
| Signal peptide at residues 1–24 | Cleavage makes the mature chain smaller than the precursor |
| Propeptide at residues 235–257 | Cleavage makes the mature chain smaller than the precursor |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | GPI-anchored FOLR1 is associated with the cell membrane | Check a membrane-enriched fraction and a FOLR1-positive control |
| Band higher than expected | N-linked glycosylation may affect migration | Compare matched samples before and after N-glycan removal |
| Band lower than expected | Signal-peptide or propeptide cleavage may reduce chain size | Confirm identity with a FOLR1-positive control and an independent antibody |
| Broad smear instead of sharp band | Variable N-linked glycosylation is possible at three listed sites | Compare matched samples before and after N-glycan removal |
| Multiple bands | Processing or glycosylation may produce different forms, though distinct bands are unproven | Check which bands persist with an independent FOLR1 antibody and after N-glycan removal |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for FOLR1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-FOLR1 antibody for Western blot: rabbit monoclonal M02254. Its catalog reports human, mouse, and rat reactivity and shows a blot of FOLR1 expression in HEK293 cell lysate. The supplied evidence shows no other tested specimens.
Which to pick: M02254 is the only listed option. Its WB image uses HEK293 cell lysate; human, mouse, and rat are listed as reactive, but the supplied image does not demonstrate performance in mouse or rat samples.